Bibliographic Info
GuidelineUpdated recommendations on treatment of adolescents and children with chronic HCV infection: policy brief.
Year of Publication2022
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Very low
We recommend treatment using pangenotypic DAA regimens for all children ages 3–5 years years with chronic hepatitis C infection, regardless of stage of disease
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics.
Year2022
InstitutionWorld Health Organization